SEC Filings

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
10-Q 10-Q 5/1/2019 3/31/2019
8-K 8-K 4/30/2019 4/30/2019
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Results of Operations and Financial Condition; Regulation FD Disclosure; and Financial Statements and Exhibits.
Proxy DEF 14A 4/26/2019 6/7/2019
Proxy DEFA14A 4/26/2019
8-K 8-K/A 4/17/2019 2/1/2019
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Completion of Acquisition or Disposition of Assets and Financial Statements and Exhibits.
8-K 8-K 4/1/2019 4/1/2019
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Regulation FD Disclosure and Financial Statements and Exhibits.
10-K 10-K 2/28/2019 12/31/2018
8-K 8-K 2/27/2019 2/27/2019
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Results of Operations and Financial Condition; Regulation FD Disclosure; and Financial Statements and Exhibits.
8-K 8-K 2/25/2019 2/25/2019
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K 8-K 2/19/2019 2/19/2019
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Regulation FD Disclosure and Financial Statements and Exhibits.
8-K 8-K 2/19/2019 2/12/2019
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Entry into a Material Definitive Agreement; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Regulation FD Disclosure; and Financial Statements and Exhibits.
13-D SC 13G/A 2/11/2019
13-D SC 13G/A 2/11/2019
8-K 8-K 2/4/2019 2/1/2019
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Regulation FD Disclosure; and Financial Statements and Exhibits.
13-D SC 13G/A 1/24/2019
8-K 8-K 1/8/2019 1/8/2019
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Regulation FD Disclosure and Financial Statements and Exhibits.
13-D SC 13D/A 11/5/2018
10-Q 10-Q 10/30/2018 9/30/2018
8-K 8-K 10/29/2018 10/29/2018
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Results of Operations and Financial Condition; Regulation FD Disclosure; and Financial Statements and Exhibits.
8-K 8-K 10/10/2018 10/9/2018
Abstract: 8-K filed by Amedisys Inc. (AMED) covering Entry into a Material Definitive Agreement; Regulation FD Disclosure; and Financial Statements and Exhibits.

Displaying 1 to 20 (of 305 filings)

Contact Information

Amedisys Corporate Headquarters
3854 American Way
Baton Rouge, LA 70816
(225) 292-2031
Amedisys Executive Office
209 10th Avenue S.
Suite 512
Nashville, TN 37203
Request Information
^
To Top